By Manasi Vaidya, Reporter, New York Sodium-glucose cotransporter-2 (SGLT2) inhibitors’ growing prominence in diabetic kidney disease...

By Bernarda Tundzhay, Reporter, London Novavax’s (NASDAQ:NVAX) NanoFlu influenza vaccine has garnered lukewarm expert predictions for its...

FROM THE PUBLISHER Our 20th issue marks the end of 2019 and I hope everyone is well as the holidays are approaching. I think the keywords...

September 2019 - December 2019 In Stunning Twist, FDA Approves Sarepta’s Duchenne Drug It Rejected The Food and Drug Administration...

North America 38th Annual J.P. Morgan Healthcare Conference January 13-16, 2020 | San Francisco, California, USA Website:...

May 2019 - August 2019 Measles Outbreak Now at 880 Cases, With Fastest Growth Still in New York There have now been 880 measles cases...

North America PAINWeek 2019 September 3-7, 2019 | Las Vegas, Nevada, USA Website: https://www.painweek.org/conferences/painweek Contact:...

By Selina Koch, Senior Editor After finally getting the message that they need to look beyond amyloid to treat Alzheimer’s disease,...

In January of this year, the cancer medicine field and the medical community at large lost a legacy. Dr. Waun Ki Hong, past division Head...

Novartis’ (SIX:NOVN) Zolgensma (onasemnogene abeparvovec-xioi) has strong potential to be used as a first-line treatment in spinal...